Concord Biotech Limited
Makvana Gajendrasinh currently serves as a Finance Executive at Concord Biotech Limited since September 2023, while also holding the position of Senior Supervisor at Cadila Pharmaceuticals Limited since February 2019. Makvana completed a Master of Commerce in Accounting from Gujarat University between July 2016 and October 2017, following a Bachelor of Commerce in Accounting from the same institution, which was obtained from July 2012 to April 2015.
Concord Biotech Limited
Concord Biotech Limited is an R&D based Biotechnology company, having focus on the fermentation, semi-synthetic and synthesis based products. Since its inception in 2000, Concord has recorded an excellent growth through diversification and process improvements. Having state-of-the-art US FDA & EUGMP approved facility; Concord is a professionally managed globally recognised supplier of fermentation based API’s and enzyme & offers services in biotechnology area like strain improvement & contract fermentation/ manufacturing. The existing portfolio of products includes API’s in the immunosuppressant, antibiotic, Oncology , Anti-Obesity, hypolipemic segments and enzymes. However, with the expertise in the field of biotechnology and chemistry, the R&D team at Concord is working towards adding new products to the product basket.